15% fall discount applied automatically at checkoutFree USA shipping over $100Free worldwide shipping over $200
Sign in 0

Tirzepatide 100mg

$429.99 or subscribe for $365.49/mo

Lot PL-2609-117 tested in our lab: 99.29% purity by HPLC Certificate PL-26-00117, analysed Sep 19, 2026 · LC-MS identity, endotoxin and sterility on the certificate · details and COA images
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Safety data sheet PL-SDS-173 GHS: Warning · H351, H361 · Read the SDS · PDF

Visa, Mastercard, Discover up to $1,000 per order (charged in MXN; your bank may add a foreign-transaction fee). Pay by Bank, Zelle, Cash App or crypto: 10% off.

Tirzepatide 100 mg, the largest fill: about 20.8 µmol of the GIP and GLP-1 receptor agonist peptide as freeze-dried powder in one sealed vial. Every lot is tested in PrymaLab’s own laboratory with a certificate. Research use only.

Description

PrymaLab · Research use only

Tirzepatide 100mg

Tirzepatide 100 mg, the largest vial in the range, about 20.8 µmol

Tirzepatide is a synthetic peptide agonist of two incretin receptors, GIP and GLP-1, made of 39 residues with a fatty diacid on lysine 20 and an amidated C-terminus. This is the largest fill PrymaLab sells: 100 mg of white lyophilized powder in one sealed vial. Its literature runs from receptor signalling to structure and diabetes trials.

Specifications

Tirzepatide 100mg at a glance
Property Value
Compound Tirzepatide LY3298176; GIP/GLP-1 receptor dual agonist
CAS number 2023788-19-2
Molecular formula C225H348N48O68
Theoretical mass 4813.5 Da
Sequence / structure H-Y-Aib-EGTFTSDYSI-Aib-LDKIAQK(2×AEEA-γGlu-C20 diacid)AFVQWLIAGGPSSGAPPPS-NH₂ (39 residues; Aib2 and Aib13; Lys20 acylated with eicosanedioic acid via γ-Glu and two AEEA spacers; C-terminal amide)
Label claim 100 mg/vial
Form Lyophilized (freeze-dried) powder or cake in a sealed glass vial with a rubber stopper and aluminium crimp cap
Storage, sealed −20 °C, desiccated, dark
Purity specification 99.0% or higher by RP-HPLC
Lot certificate Results for the lot now shipping are in the certificate panel on this page
Safety data sheet PL-SDS-173

Other fills

This is the 100 mg fill. The Tirzepatide 10mg page is the main listing for this compound, with the full research summary and every fill side by side. Other fills: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 80 mg.

Keeping moisture out

The certificate for each lot reports its water content by the Karl Fischer method, and the panel on this page shows the figure for the lot now shipping. To keep further water out, hold the sealed vial at −20 °C, desiccated and dark, and let it warm to room temperature before opening so condensation does not form on the cold powder.

What the research covers

Tirzepatide engages the GIP receptor more strongly than the GLP-1 receptor and shows signalling bias at the latter, according to Willard and colleagues1. A 100 mg vial adds only quantity, kept as a solid, and Wang’s review of freeze-dried proteins notes that a solid can still have limited long-term storage stability even after successful lyophilization2. The Tirzepatide 10 mg page holds the full research summary.

The Retatrutide vs Tirzepatide guide covers the literature in more depth.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. The results for the lot now shipping are in the certificate panel on this page, and the certificate number, key and QR code can be checked on the verify page. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

How much peptide is 100 mg in micromoles?

About 20.8 µmol, using the theoretical mass of 4813.5 Da on the certificate. Residual water in the powder makes the real amount a little smaller.

Is the largest fill tested any differently?

No. It goes through the same five release tests as every other size, listed in the testing section below, and is made as its own lot under its own certificate number.

References

  1. Willard FS, Douros JD, Gabe MB, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020;5(17). DOI · PubMed
  2. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. DOI · PubMed

Research use only

For laboratory research use only. Tirzepatide 100mg is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Additional information

Weight 0.1 lbs
Dimensions N/A

Lot PL-2609-117 · Certificate of Analysis PL-26-00117

Every lot is tested in our own laboratory before it ships. These are the reference facts for this compound and the results for the lot currently shipping. Open the certificate page to verify it by QR code or number.

CompoundTirzepatide
LY3298176; GIP/GLP-1 receptor dual agonist
CAS number2023788-19-2
Molecular formulaC225H348N48O68
Theoretical mass4813.5 Da
Sequence / structureH-Y-Aib-EGTFTSDYSI-Aib-LDKIAQK(2×AEEA-γGlu-C20 diacid)AFVQWLIAGGPSSGAPPPS-NH₂ (39 residues; Aib2 and Aib13; Lys20 acylated with eicosanedioic acid via γ-Glu and two AEEA spacers; C-terminal amide)
AppearanceWhite lyophilized powder
Storage−20 °C, desiccated, dark
Label claim100 mg/vial
Lot numberPL-2609-117
Certificate numberPL-26-00117
Date of analysis2026-09-19 (retest 2028-09-18)
Purity (RP-HPLC)99.29%
Identity (LC-MS)4813.6 Da
Water content (KF)2.2%
Endotoxin (LAL)0.08 EU/mg
SterilityNo growth; conforms
ConclusionPASS
Tested byPrymaLab Analytical (PrymaLab's own laboratory, Ashland, KY). In-house result, not an independent third-party test.
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Certificate of analysis for lot PL-2609-117, page 1
Certificate page 1: results
Certificate of analysis for lot PL-2609-117, page 2
Certificate page 2: method and approval

Safety data sheet PL-SDS-173 · Tirzepatide

GHS safety data sheet for this product (lyophilized powder, vial), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Warning
  • H351 Suspected of causing cancer.
  • H361 Suspected of damaging fertility or the unborn child.
CompositionTirzepatide (CAS 2023788-19-2) · ≥ 95% (dry basis, as supplied), 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 80 mg, 100 mg per vial
ClassificationCarcinogenicity (Category 2); Reproductive toxicity (Category 2)
Physical stateSolid. White to off-white lyophilized powder.
Storage−20 °C (sealed vial), desiccated and protected from light; 2–8 °C acceptable for short periods
HandlingOpen vials only in a clean area. Avoid generating or inhaling dust; weigh or reconstitute inside a ventilated enclosure when the full contents are handled as a dry powder. Reconstitute by adding diluent slowly to the vial wall; do not shake. Wash hands after handling.
First aidEyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
DisposalChemical waste through a licensed contractor; do not pour down the drain.
TransportNot regulated as a dangerous good (DOT / IATA / IMDG).

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Peptide Research Articles

How to reconstitute tirzepatide showing vial of lyophilized powder and bacteriostatic water for compounded tirzepatide mixing

How to Reconstitute Tirzepatide: Concentration and Storage

Tirzepatide is a 39-residue dual GIP and GLP-1 receptor agonist. This guide covers how the lyophilized peptide is dissolved and stored in the laboratory, how concentration is calculated and what the SURPASS and SURMOUNT trials measured.

24-hour support icon
24/7 Online support

support@prymalab.net info@prymalab.net

Quality guarantee badge icon
7-day returns

7-day returns on unopened, sealed products, plus our third-party testing guarantee.

Shipping truck icon
Free US shipping

Free USA shipping over $100 and free worldwide shipping over $200.

RealReviews.io Rate your experience with PrymaLab